Sealant applicator with mixing and ejection assembly with extendable
By designing a short, stretchable jet tip assembly, the problem of applying tissue sealant and hemostasis in small spaces in minimally invasive surgery is solved, and the effect of effectively controlling bleeding in minimally invasive surgery is achieved.
Patent Information
- Application Number
- CN202380031370.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-03-31
- Filing Date
- 2023-03-15
- Publication Date
- 2024-11-15
AI Technical Summary
In minimally invasive surgery, especially in small, confined spaces, such as the chest cavity, it is difficult to effectively apply tissue sealants and hemostasis to control bleeding.
A short, extendable jet tip assembly is designed to enable the jet tip to bend in a small space and maintain an effective distance through a flexible shaft and a stretchable wire catheter, ensuring good jet quality for tissue sealant and hemostatic agent.
This assembly enables tissue sealant and hemostatic agent to be effectively applied in a narrow surgical site, reducing the risk of bleeding during surgery and improving operational flexibility in small spaces.
Smart Images

Figure CN118973490A_ABST
Abstract
Description
Background Art Technical Field
[0001] The present patent application relates to medical devices, and more particularly to systems, devices and methods for extruding tissue sealants and hemostats during surgical procedures.
[0002] Description of Related Technology
[0003] Mammals may suffer from bleeding due to wounds or during surgical procedures. In some cases, the bleeding is minor and will stop due to normal clotting or by using simple first aid techniques. However, in other cases, excessive bleeding may occur, which requires the use of specialized equipment and materials, as well as the services of trained personnel, in order to administer effective rescue.
[0004] In order to solve the above more challenging situations, various materials have been developed for controlling excessive bleeding. For example, local absorbable hemostats (TAHs) are widely used in surgical applications. TAHs include products based on oxidized cellulose (OC), oxidized regenerated cellulose (ORC), gelatin, collagen, chitin, chitosan, starch, etc. In order to improve hemostatic properties, scaffolds based on the above materials can be combined with coagulation factors of biological origin (such as thrombin and fibrinogen).
[0005] In surgical procedures, bleeding control is key to minimizing blood loss, shortening surgical duration, and reducing postoperative complications.
[0006] In recent years, minimally invasive surgery (MIS) techniques have emerged as an alternative to conventional surgical techniques to perform a variety of surgical procedures. MIS procedures differ from conventional surgical procedures in that multiple devices and / or surgical tools can be introduced into the body through cannulas and trocars inserted into small incisions made in the body. Due to the use of MIS techniques, trauma to the body is reduced, which shortens the patient's recovery time.
[0007] One type of minimally invasive surgery involves laparoscopic surgery, which is used to treat hernias, colon disease, gastroesophageal reflux disease, gallbladder disorders, lung disorders, etc. Typically, patients who undergo laparoscopic surgery are able to return home after a short recovery period (within hours after undergoing surgery).
[0008] One challenge that arises when performing MIS surgery involves controlling bleeding at the surgical site.During laparoscopic surgery, the surgeon has significantly less access to the surgical site or cavity than during conventional open surgery.
[0009] In response, tissue sealants and other bioadhesive materials have been developed for closing incisions and wounds at surgical sites. Tissue sealants may include fibrin sealants, which include thrombin and fibrinogen, but other preparations are available. Typically, the individual components of tissue sealants (e.g., thrombin and fibrinogen) are stored in isolated reservoirs, respectively, because once they contact each other, these components will react rapidly. In many cases, these two individual components are mixed together for the first time before being applied to tissue.
[0010] Once mixed, the components coagulate very quickly, producing an adhesive gel within a short period of time (eg, within 10 to 20 seconds).
[0011] There have been some developments related to systems for extruding tissue sealants. For example, U.S. Pat. No. 6,458,095 discloses a dispenser for simultaneously dispensing a first component and a second component of an adhesive tissue sealant, wherein at least the first component is stored in the dispenser as a dry powder that is dissolved by the introduction of a solvent prior to use. The dispenser includes a first container having a first septum at one end, an open end opposite the first septum, and a first removable plug disposed therein. The first container holds a certain amount of the first component stored in dry powder form between the first septum and the first removable plug. The dispenser includes a second container having a second septum at one end, an open end opposite the second septum, and a second removable plug disposed therein, and the second container holds a certain amount of the second component.
[0012] U.S. Patent No. 10,183,132 assigned to Ethicon LLC (the disclosure of which is hereby incorporated by reference herein) teaches an integrated delivery device that can be operated with one hand and delivers a liquid medicament and a powder medicament to a tissue or wound from a liquid medicament extrusion subunit and a powder medicament extrusion subunit. Each extrusion subunit has an actuator for the liquid medicament and the powder medicament contained therein positioned proximate to each other at the proximal end of the extrusion subunit and a delivery cannula for each of the extrusion subunits positioned proximate to each other at the distal end of the extrusion subunit.
[0013] U.S. Patent No. 10,507,293 (the disclosure of which is hereby incorporated by reference herein) to Goodman et al., assigned to Ethicon, Somerville, New Jersey, teaches a device for extruding hemostatic powder. The device has an elongated reservoir having a manual air pump such as a bellows at the proximal end and an extrusion port at the distal end. A porous filter is slidably disposed in the reservoir between the bellows and the plunger and the extrusion port, and a spring is disposed in the reservoir between the air pump and the plunger. Powder is disposed in the reservoir between the porous filter and the extrusion port, and the pump is in fluid communication with the extrusion port through the porous filter and through the powder.
[0014] US2021 / 0101162 assigned to Ethicon Corporation discloses a spray device (the disclosure of which is hereby incorporated by reference herein), the spray device including a first spray tip having a first fluid passage defining a first flow area and a second spray tip including a second fluid passage defining a second flow area, the second flow area being greater than the first flow area of the first spray tip. The first spray tip and the second spray tip are juxtaposed and spaced apart from each other at the distal end of the spray device. When a first fluid having a certain volume flow rate is introduced into the first spray tip and a second fluid having the same certain volume flow rate is introduced into the second spray tip, the first fluid will flow through the first fluid passage at a greater speed than the speed at which the second fluid flows through the second fluid passage.
[0015] Despite the above advances, there is a continuing need for improved systems, devices and methods for delivering tissue sealants and hemostats to patients to control bleeding. There is also a need for sealant application devices used in minimally invasive surgery that enable tissue sealants and hemostats to be delivered to confined spaces and small surgical sites within a patient's body. Summary of the invention
[0016] During minimally invasive surgery, it may be necessary to apply a tissue sealant in a small, confined space. For example, the chest cavity is a small, confined space, which makes it difficult for a conventional spray tip to fit within the cavity and far enough from the lung surface to achieve a good spray quality that will effectively seal the lung tissue. In response to these issues, the present patent application discloses a short, ductile spray tip assembly that enables the spray tip to bend within a small, confined space and still be far enough from the lung surface to achieve a good spray quality.
[0017] In one embodiment, a sealant applicator for extruding a tissue sealant or hemostat preferably has a mixing and spraying assembly including a spray tip assembly separated from the mixing assembly by a stretchable section, the stretchable section including a flexible shaft that houses a stretchable wire. The stretchable section enables the spray tip assembly to be angled relative to the mixing assembly. The spray tip assembly has a shorter length and a smaller outer diameter, which enables the spray tip assembly to be positioned in smaller spaces and narrower body cavities for effective extrusion of tissue sealants and hemostat onto tissue.
[0018] In one embodiment, a mixing and spraying assembly for a tissue sealant preferably includes a mixing assembly at a proximal end of the mixing and spraying assembly, a spray tip assembly at a distal end of the mixing and spraying assembly, and an extendable section having a proximal end connected to the mixing assembly and a distal end connected to the spray tip assembly so that the spray tip assembly can be angled relative to the mixing assembly.
[0019] In one embodiment, the stretchable section includes: a flexible shaft having a proximal end, a distal end, and a length extending between the proximal end and the distal end of the flexible shaft; a stretchable wire conduit extending along the length of the flexible shaft; and a stretchable wire disposed in the stretchable wire conduit of the flexible shaft.
[0020] In one embodiment, the length of the ductile wire is greater than the length of the flexible shaft. In one embodiment, the ductile wire has a proximal end extending beyond the proximal end of the flexible shaft and connected to the mixing assembly, and a distal end extending beyond the distal end of the flexible shaft and connected to the spray tip assembly.
[0021] In one embodiment, a mixing assembly includes a mixer housing having a proximal end, a distal end, and a mixer housing conduit extending along a length of the mixer housing from the proximal end to the distal end of the mixer housing.
[0022] In one embodiment, the mixing element is disposed within the mixer housing conduit. In one embodiment, a proximal end of a ductile wire extending beyond a proximal end of the flexible shaft is secured to the mixing element.
[0023] In one embodiment, the mixing element preferably comprises a static mixer having a central axis extending along the length of the static mixer, the central axis having a proximal end and a distal end. In one embodiment, a blind hole may be formed in the central axis of the static mixer, the blind hole extending from the distal end of the central axis toward the proximal end of the central axis. The blind hole may extend about 1 / 2 to 3 / 4 of the length of the central axis of the static mixer.
[0024] In one embodiment, the proximal end of the ductile wire may be disposed in the blind hole formed in the central shaft of the static mixer for connecting the proximal end of the ductile wire to the static mixer.
[0025] In one embodiment, the mixing assembly may include a proximal connector having a proximal end configured for insertion into an opening at a distal end of an elongated cannula of a sealant applicator device and a distal end having external threads.
[0026] In one embodiment, the mixer housing preferably has internal threads at the proximal end of the mixer housing, the internal threads being configured to engage with the external threads at the distal end of the proximal connector for securing the mixer housing to the proximal connector.
[0027] In one embodiment, the proximal connector may have a first fluid channel extending from the proximal end to the distal end of the proximal connector, whereby the first fluid channel is in fluid communication with the proximal end of the static mixer.
[0028] In one embodiment, the proximal connector may have a second fluid channel extending from the proximal end to the distal end of the proximal connector, whereby the second fluid channel is in fluid communication with the proximal end of the static mixer.
[0029] In one embodiment, the first fluid pathway and the second fluid pathway extending through the proximal connector are separate and / or isolated from each other.
[0030] In one embodiment, a first flexible tube may be disposed in the first fluid passage of the proximal connector for supplying the first fluid to the proximal end of the mixer housing.
[0031] In one embodiment, a second flexible tube may be disposed in the second fluid passage of the proximal connector for supplying a second fluid to the proximal end of the mixer housing.
[0032] In one embodiment, the static mixer is adapted to mix a first fluid and a second fluid whereupon the first fluid and the second fluid react together to form a tissue sealant that is extrudable from the spray tip assembly.
[0033] In one embodiment, the flexible shaft of the extendable section may have one or more tissue sealant conduits extending along its length for supplying tissue sealant from the mixing assembly to the spray tip assembly. The tissue sealant preferably flows downstream through the tissue sealant conduits for supply to the spray tip assembly.
[0034] In one embodiment, the stretch wire conduit extends along a central axis of the flexible shaft, and the one or more tissue sealant conduits of the flexible shaft include first and second tissue sealant conduits extending along opposite sides of the stretch wire conduit.
[0035] In one embodiment, the spray tip assembly may include a distal connector having a proximal end and an externally threaded distal end. In one embodiment, the proximal end of the distal connector has a central opening that seats the distal end of the flexible shaft.
[0036] In one embodiment, the distal end of the ductile wire extending beyond the distal end of the flexible shaft is connected to the distal connector.
[0037] In one embodiment, the spray tip assembly may include a spray cup having a spray opening for extruding tissue sealant supplied through the first tissue sealant conduit and the second tissue sealant conduit of the flexible shaft.
[0038] In one embodiment, the spray cup has a tubular proximal end with internal threads configured to engage external threads at the distal end of the distal connector for securing the spray cup to the distal connector.
[0039] In one embodiment, the distal end of the ductile wire secured to the distal connector of the spray tip assembly may have a paddle flange having a width greater than the diameter of the section of the ductile wire extending to the proximal end of the ductile wire.
[0040] In one embodiment, a mixing and spraying assembly for extruding a tissue sealant preferably includes: a mixing assembly configured to mix a first fluid and a second fluid that chemically react together to form a tissue sealant; a spray tip assembly configured to extrude the tissue sealant; and an extendable section having a proximal end connected to the mixing assembly and a distal end connected to the spray tip assembly to enable the spray tip assembly to be angled relative to the mixing assembly.
[0041] In one embodiment, the extendable section has one or more tissue sealant conduits extending along its length for delivering tissue sealant from the mixing assembly to the spray tip assembly.
[0042] In one embodiment, the extendable section desirably includes a flexible shaft having an extendable wire conduit extending from a proximal end thereof to a distal end thereof and an extendable wire disposed within the extendable wire conduit.
[0043] In one embodiment, the ductile wire preferably has a proximal end extending beyond the flexible shaft for connection to the proximal end of the mixing assembly and a distal end extending beyond the distal end of the flexible shaft for connection to the spray tip assembly.
[0044] In one embodiment, the mixing assembly desirably includes a mixer housing having a proximal end, a distal end, and a mixer housing conduit extending from the proximal end to the distal end of the mixer housing.
[0045] In one embodiment, the mixing assembly may include a mixing element disposed within a mixer housing conduit of the mixer housing.
[0046] In one embodiment, the spray tip assembly preferably includes a distal connector coupled to the distal end of the flexible shaft and a spray cup having a spray opening secured to the distal end of the distal connector.
[0047] In one embodiment, the proximal end of the ductile wire is preferably secured to a mixing element disposed within the mixer housing, and the distal end of the ductile wire is preferably secured to a distal connector of the spray tip assembly.
[0048] In one embodiment, the mixing element preferably comprises a static mixer having a central axis extending along the length of the static mixer. In one embodiment, the central axis of the static mixer has a proximal end and a distal end. In one embodiment, a blind hole is formed in the central axis of the static mixer, and the blind hole extends from the distal end of the central axis toward the proximal end of the central axis. In one embodiment, the proximal end of a ductile wire is arranged in the blind hole formed in the central axis of the static mixer, for connecting the proximal end of the ductile wire to the static mixer.
[0049] In one embodiment, the mixer housing has a longitudinal axis extending from a proximal end to a distal end of the mixer housing.In one embodiment, the ductile section enables the spray tip assembly to be angled relative to the longitudinal axis of the mixer housing.
[0050] In one embodiment, the mixer housing has a first outer diameter and the spray tip assembly has a second outer diameter that is smaller than the first outer diameter of the mixer housing.
[0051] In one embodiment, a method of extruding a tissue sealant preferably includes obtaining a mixing and spraying assembly, the mixing and spraying assembly comprising a mixing assembly, a spray tip assembly, and an expandable section having a proximal end connected to the mixing assembly and a distal end connected to the spray tip assembly, for spacing the spray tip assembly from the mixing assembly and for enabling the spray tip assembly to be angled relative to the mixing assembly.
[0052] In one embodiment, the method may include directing a first fluid and a second fluid into a proximal end of a mixing assembly, and mixing the first fluid and the second fluid within the mixing assembly, whereupon the first fluid and the second fluid react together to form a tissue sealant.
[0053] In one embodiment, the method may include passing a tissue sealant through one or more tissue sealant conduits extending through the expandable section to supply the tissue sealant to the spray tip assembly, and extruding the tissue sealant from a distal end of the spray tip assembly.
[0054] In one embodiment, the first fluid may include fibrinogen and the second fluid may include thrombin that reacts with the fibrinogen to form a tissue sealant.
[0055] In one embodiment, the ductile section of the mixing and spraying assembly advantageously comprises a flexible shaft having a ductile wire conduit extending from its proximal end to its distal end and a ductile wire disposed within the ductile wire conduit. In one embodiment, the ductile wire has a proximal end extending beyond the proximal end of the flexible shaft and a distal end extending beyond the distal end of the flexible shaft. In one embodiment, the proximal end of the ductile wire is connected to the mixing assembly, and the distal end of the ductile wire is connected to the spray tip assembly.
[0056] The systems, devices, and methods disclosed herein are not limited to use within the thoracic cavity and may be used anywhere on a patient's body to extrude a tissue sealant and / or hemostatic agent.
[0057] These and other preferred embodiments of the present patent application are described in more detail herein. BRIEF DESCRIPTION OF THE DRAWINGS
[0058] Figure 1 is a perspective view of a sealant application device including a syringe assembly, a sealant delivery assembly, and a mixing and spraying assembly according to one embodiment of the present patent application.
[0059] Figure 2yes Figure 1 A perspective view of the syringe assembly shown in FIG.
[0060] Figure 3 yes Figure 1 An exploded view of the proximal end of the syringe assembly and sealant delivery assembly is shown in FIG.
[0061] Figure 4A yes Figure 1 A cross-sectional view of the proximal end of the syringe assembly and sealant delivery assembly shown in FIG.
[0062] Figure 4B yes Figure 4A An enlarged view of the distal end of the syringe assembly and the proximal end of the sealant delivery assembly is shown in FIG.
[0063] Figure 5 yes Figure 1 A perspective view of the sealant delivery assembly and the mixing and spraying assembly shown in FIG.
[0064] Figure 6 yes Figure 1 A perspective view of the proximal end of the syringe assembly and sealant delivery assembly shown in FIG.
[0065] Figure 7 is located in Figure 1 A perspective view of a mixing and spraying assembly at a distal end of a sealant applicator shown in FIG. 1 , comprising a mixing assembly, an expandable section, and a spraying tip assembly.
[0066] Figure 8 yes Figure 7 Exploded view of the mixing and injection assembly shown in .
[0067] Fig. 9A yes Figure 7 An exploded view of the spray tip assembly including the distal connector and spray cup is shown in FIG.
[0068] Fig. 9B yes Fig. 9A Another exploded view of the spray tip assembly including the distal connector and spray cup is shown in .
[0069] Fig.10 yes Fig. 9A and Fig. 9B A proximal end view of the distal connector shown in FIG.
[0070] Fig.11 yes Fig. 9A and Fig. 9B Proximal end view of the spray cup shown in .
[0071] Fig.12 yes Figure 7 and Figure 8 A partial assembly diagram of the mixing and injection assembly is shown in FIG.
[0072] Fig.13A yes Figure 7 A cross-sectional view of the mixing and injection assembly is shown in FIG.
[0073] Fig. 13B yes Figure 7 A perspective cutaway view of the mixing and injection assembly shown in FIG.
[0074] Fig.14A yes Figure 1 and Figure 7 A cross-sectional view of the mixing and injection assembly is shown in FIG.
[0075] Fig. 14B yes Figure 1 and Figure 7 A perspective cutaway view of the mixing and injection assembly shown in FIG.
[0076] Fig.15 yes Figure 1 and Figure 7 A perspective view of a mixing and spraying assembly shown in FIG. 1 , which is in a straight configuration and includes a mixing assembly, an extendable section, and a spray tip assembly.
[0077] Fig.16 yes Fig.15 A perspective view of a mixing and spraying assembly of FIG. 1 , wherein the extendable section is in a bent configuration such that the spray tip assembly is angled relative to the mixing assembly.
[0078] Fig.17 Is a conventional spray tip with Fig.16 A side-by-side view of the mixing and injection assembly shown in FIG.
[0079] Fig.18 Illustrated is the vial assembly with Figure 1 and Figure 2 The first stage of the method of connecting the distal end of the syringe assembly is shown.
[0080] Fig.19 The vial assembly is shown after the proximal end of the vial assembly has been connected to the distal end of the syringe assembly. Fig.18 Vial assembly and syringe assembly.
[0081] Fig. 20 An example of using according to one embodiment of the present patent application is Fig.19 A method of mixing a first fluid with a first powder and a second fluid with a second powder using a syringe assembly and a vial assembly. DETAILED DESCRIPTION
[0082] Figure 1In one embodiment, a sealant applicator 100 for extruding a tissue sealant and / or hemostatic agent during a surgical procedure preferably includes a syringe assembly 102, a sealant delivery assembly 104, and a mixing and spraying assembly 106. In one embodiment, the sealant delivery assembly 104 is secured to the distal end of the syringe assembly 102, and the mixing and spraying assembly 106 is secured to the distal end of the sealant delivery assembly 104.
[0083] In one embodiment, the mixing and spraying assembly 106 preferably includes a mixing assembly 108, an expandable section 110, and a spray tip assembly 112. The expandable section 110 preferably interconnects the distal end of the mixing assembly 108 and the proximal end of the spray tip assembly 112 to enable the spray tip assembly 112 to be angled and / or oriented at different angles relative to the longitudinal axis A1 of the elongated cannula of the sealant delivery assembly 104.
[0084] refer to Figure 2 In one embodiment, the sealant application device 100 ( Figure 1 ) preferably includes a double-barrel syringe 114 having a first syringe barrel 116A adapted to receive a first fluid and a second syringe barrel 116B adapted to receive a second fluid mixed with the first fluid to form a tissue sealant. In one embodiment, the syringe assembly 102 preferably includes a double-barrel plunger 118, which includes a first plunger rod 120A that can be inserted into the first syringe barrel 116A and a second plunger rod 120B that can be inserted into the second syringe barrel 116B. The syringe assembly 102 preferably includes a protrusion 122 (e.g., a thumb protrusion) interconnecting the proximal end of the first plunger rod 120A and the proximal end of the second plunger rod 120B.
[0085] In one embodiment, the syringe assembly 102 preferably includes a first dispensing tip 124A located at the distal end of the first syringe barrel 116A and a second dispensing tip 124B located at the distal end of the second syringe barrel 116B.
[0086] In one embodiment, a first fluid (e.g., a first sealant precursor; an activating fluid; a buffer solution) may be disposed in a first fluid chamber of the first syringe barrel 116A and a second fluid (e.g., a second sealant precursor; an activating fluid; a buffer solution) may be disposed in a second fluid chamber of the second syringe barrel 116B. In one embodiment, the tab 122 may be depressed in the distal direction DIR1 to force the first and second fluids to be dispensed via respective first and second dispensing tips 124A, 124B at the distal ends of the first and second syringe barrels 116A, 116B.
[0087] In one embodiment, the first fluid and the second fluid can be a first tissue sealant precursor and a second tissue sealant precursor that are mixed together to form a tissue sealant or hemostat that can be extruded from the distal end of the sealant applicator 100. In one embodiment, the first fluid and the second fluid preferably react when mixed with each other to form a tissue sealant or hemostat. In one embodiment, the first fluid and the second fluid are preferably isolated from each other until directed to the mixing and spraying assembly 106 ( Figure 1 ), whereupon the first fluid and the second fluid are mixed together and ejected from a spray tip assembly 112 ( Figure 1 )Extrude.
[0088] refer to Figure 3 In one embodiment, the syringe assembly 102 preferably includes a first plunger 126A that can be fixed to the distal end of the first plunger rod 120A and a second plunger 126B that can be fixed to the distal end of the second plunger rod 120B. In one embodiment, the outer periphery of the first plunger 126B preferably forms a fluid seal with the inner surface of the first syringe barrel 116A, and the outer periphery of the second plunger 126B preferably forms a fluid-tight seal with the inner surface of the second syringe barrel 116B. When the double-barrel plunger 118 moves in the distal direction DIR1 relative to the first syringe barrel 116A and the second syringe barrel 116B, the first plunger 126A forces the first fluid to flow out of the first dispensing top 124A, and the second plunger 126B forces the second fluid to flow out of the second dispensing top 124B.
[0089] In one embodiment, the sealant delivery assembly 104 ( Figure 1 ) preferably includes a sealant delivery housing 128 having a first housing component 130A and a second housing component 130B. In one embodiment, the first housing component 130A and the second housing component 130B of the sealant delivery housing 128 can be snap-fitted together. In one embodiment, the sealant delivery housing is adapted to be secured to the distal end of the syringe assembly 102. In one embodiment, the distal end of the syringe assembly 102 desirably includes a latch mechanism 135 that is configured to engage a latch opening 135 formed in the first housing component 130A of the sealant delivery housing 128. In one embodiment, the latch mechanism 135 is movable between a first position (e.g., an extended position) for locking the sealant delivery housing to the distal end of the syringe assembly and a second position (e.g., a depressed position) for releasing the attachment of the sealant delivery housing to the distal end of the syringe assembly 102.
[0090] In one embodiment, the sealant delivery assembly 104 preferably includes a connector 132 interconnecting a first hub 134A (e.g., a first fluid port) and a second hub 134B (e.g., a second fluid port). In one embodiment, when the proximal end of the sealant delivery assembly 104 is coupled to the distal end of the syringe assembly 102, the first dispensing tip 124A of the first syringe barrel 116A is preferably inserted into the first hub 134A, and the second dispensing tip 124B of the second syringe barrel 116B is inserted into the second hub 134B to provide fluid communication between the first and second syringe barrels and the respective first and second hubs 134A, 134B.
[0091] In one embodiment, the sealant delivery assembly 104 preferably includes an elongated cannula 136 (e.g., an elongated tubular shaft) that preferably extends between a proximal end and a distal end of the sealant delivery assembly. The elongated cannula 136 can be rigid. In one embodiment, a first flexible tube 138A and a second flexible tube 138B are disposed within the elongated cannula 136 for delivering the first fluid and the second fluid to a portion of the sealant delivery assembly 100 ( Figure 1 ) is preferably connected to the mixing and injection assembly 106 at the distal end of the first hub 134A. In one embodiment, the proximal end 140A of the first flexible tube 138A is preferably in fluid communication with the distal end of the first hub 134A, and the proximal end 140B of the second flexible tube 138B is preferably in fluid communication with the distal end of the second hub 134B. In one embodiment, the first fluid supplied from the first syringe barrel 116A preferably passes through the first flexible tube 138A, and the second fluid supplied from the second syringe barrel 116B preferably passes through the second flexible tube 138B.
[0092] refer to Figure 4A and 4B In one embodiment, the proximal end of the sealant delivery assembly 104 is configured to be connected to the distal end of the syringe assembly 102. The syringe assembly 102 preferably includes a first syringe barrel 116A and a second syringe barrel 116B. The distal end of the first plunger 126A and the first plunger rod 120A are preferably inserted into the proximal end of the first fluid chamber 142A of the first syringe barrel 116A for forcing the first fluid to flow out of the first dispensing top 124A of the first syringe barrel 116A. The distal end of the second plunger 126B and the second plunger rod 120B are preferably inserted into the proximal side of the second fluid chamber 142B of the second syringe barrel 116B for forcing the second fluid to flow out of the second dispensing top 124B of the second syringe barrel 116B.
[0093] In one embodiment, the first dispensing tip 124A at the distal end of the first syringe barrel 116A is preferably inserted into the first hub 134A, and the second dispensing tip 124B at the distal end of the second syringe barrel 116B is preferably inserted into the second hub 134B.
[0094] In one embodiment, the proximal end 140A of the first flexible tube 138A is inserted into the distal end of the first hub 134A for providing fluid communication between the first fluid chamber 142A of the first syringe barrel 116A and the first flexible tube 138A. In one embodiment, the proximal end 140B of the second flexible tube 138B is inserted into the distal end of the second hub 134B for providing fluid communication between the second fluid chamber 142B of the second syringe barrel 116B and the second flexible tube 138B.
[0095] The first flexible tube 138A and the second flexible tube 138B are disposed within the elongated cannula 136 which is connected to the sealant delivery housing 128 at the distal end thereof and is located at the sealant application device 100 ( Figure 1 ) extends between the mixing and injection assembly 106 at the distal end of the .
[0096] refer to Figure 5 In one embodiment, the sealant application device 100 preferably includes a sealant delivery assembly 104 and a mixing and spraying assembly 106 connected to the distal end of an elongated cannula 136 of the sealant delivery assembly 104. In one embodiment, the sealant delivery assembly 104 preferably includes a sealant delivery housing 128 having a first housing component 130A and a second housing component 130B that preferably snap fit together. The elongated cannula 136 has a proximal end connected to the sealant delivery housing 128 and a distal end connected to the mixing and spraying assembly 106. The elongated cannula 136 is preferably rigid and extends along a longitudinal axis A1. In one embodiment, the elongated cannula 136 can be a hollow tube made of a biocompatible material such as a metal (e.g., stainless steel) or a polymer.
[0097] In one embodiment, the mixing and spraying assembly 106 preferably includes a mixing assembly 108, a ductile section 110, and a spray tip assembly 112. In one embodiment, the ductile section 110 enables the spray tip assembly 112 to be angled relative to the longitudinal axis A1 of the mixing assembly 108 and / or the elongated cannula 136. The ductile section 110 can accommodate a ductile wire having shape memory properties for enabling the spray tip assembly 112 to be angled relative to the longitudinal axis of the mixing assembly 108 and / or the elongated cannula 136.
[0098] refer to Figure 6In one embodiment, the proximal end of the sealant applicator 100 preferably includes a syringe assembly 102 and a sealant delivery assembly 104. In one embodiment, the syringe assembly 102 preferably includes a locking assembly 144 that includes a resilient latch 125 that engages a latch opening 135 formed in a first portion 130A of a sealant delivery housing 128 to selectively lock the sealant assembly housing 128 to the distal end of the syringe assembly 102. In one embodiment, the locking assembly 144 can be depressed to disconnect the resilient latch 125 from the latch opening 135 so that the sealant delivery assembly 104 can be disconnected from the fixed connection with the distal end of the syringe assembly 102.
[0099] refer to Figure 7 In one embodiment, the mixing and spraying assembly 106 is preferably fixed to the distal end of the elongated conduit 136 of the sealant delivery assembly 104. The mixing and spraying assembly 106 preferably includes a mixing assembly 108, an expandable section 110, and a spray tip assembly 112 connected to the distal end of the expandable section 110. In one embodiment, the first fluid and the second fluid delivered by the sealant delivery assembly 104 are directed into the proximal end 146 of the mixing assembly 108. As the first fluid and the second fluid flow downstream between the proximal end 146 and the distal end 148 of the mixing assembly 108, the first fluid and the second fluid are advantageously mixed together within the mixing assembly 108. The expandable section 110 is located distally (i.e., downstream) of the distal end 148 of the mixing assembly 108 and proximally (i.e., upstream) of the proximal end of the spray tip assembly 112. Thus, the expandable section 110 spaces the spray tip assembly 112 from the mixing assembly 108.
[0100] refer to Figure 8 In one embodiment, the mixing and spraying assembly 106 preferably includes a mixing assembly 108, an extendable section 110, and a spray tip assembly 112. The mixing assembly 108 preferably includes a mixer housing 150 having an elongated conduit 152 extending from a proximal end 154 to a distal end 156 of the mixer housing 150. In one embodiment, the mixing assembly 108 preferably includes a mixing element 158 (e.g., a static mixer) disposed within the elongated conduit 152 of the mixer housing 150. In one embodiment, the mixing element 158 preferably includes a plurality of mixing fins 160 spaced apart from one another along the length of the mixing element 158. The mixing element 158 is configured to mix the first fluid and the second fluid together as the first fluid and the second fluid flow through the mixer housing 150.
[0101] In one embodiment, the mixing assembly 108 preferably includes a proximal connector 162 ( Figure 7), the proximal connector has a slender cannula 136 ( Figure 7 ) and a distal end 166 having external threads 168 adapted to engage with internal threads (not shown) located at the proximal end 154 of the mixer housing 150. The proximal connector 162 has a first flexible tube 138A ( Figure 4B ) and the first fluid passage 170A in fluid communication with the second flexible tube 138B ( Figure 4B ) fluidly connected to the second fluid channel 170B. When the first fluid channel and the second fluid channel pass through the length of the proximal connector, they are preferably separated and / or isolated from each other. The first fluid channel 170A and the second fluid channel 170B preferably guide the first fluid and the second fluid into the proximal end 154 of the mixer housing 150, so that the first fluid and the second fluid are mixed together through the mixing fins 160 of the mixing element 158.
[0102] In one embodiment, the ductile section 110 of the mixing and spraying assembly 106 preferably includes a flexible shaft 172 (e.g., a flexible tube; a flexible member) having a proximal end 174 and a distal end 176. The flexible shaft can be made of a polymer material (e.g., rubber). The flexible shaft 172 advantageously has a ductile wire opening 178 and a first tissue sealant opening 180A and a second tissue sealant opening 180B extending along the length of the flexible shaft 172. In one embodiment, the ductile section 110 preferably includes a ductile wire 182 that is formed to extend through the ductile wire opening 178 of the flexible shaft 172. The extensible wire 182 preferably has a proximal end 184 configured for connection to the mixing element 158 and a distal end 186 including a paddle-shaped flange 188 having a width greater than the outer diameter of the extensible wire 182, the extensible wire extending from the paddle-shaped flange 188 in a proximal direction.
[0103] refer to Figure 8 and FIG. 9A to FIG. 9B In one embodiment, the spray tip assembly 112 of the mixing and spraying assembly 106 preferably includes a distal connector 190 having a proximal end 192 and a distal end 194 having external threads 196. In one embodiment, the proximal end 192 of the distal connector 190 is preferably configured to receive the distal end 176 of the flexible shaft 172 and the distal end 186 of the ductile pin 182.
[0104] In one embodiment, the spray tip assembly 112 of the mixing and spraying assembly 106 advantageously includes a spray cup 198 having a spray opening 200. The spray cup 198 preferably has internal threads (not shown) that engage with external threads 196 at the distal end 194 of the distal connector 190 for securing the spray cup 198 to the distal connector 190.
[0105] refer to Fig. 9B and Fig.10 In one embodiment, the proximal end 192 of the distal connector 190 has a proximal opening 193 adapted to receive the distal end 176 of the flexible shaft 172. The distal connector 190 preferably includes a first tissue sealant opening 195A and a second tissue sealant opening 195B that direct the tissue sealant into the proximal end of the injection cup 198 for extrusion through the injection opening 200 of the injection cup 198.
[0106] refer to Fig. 9B and Fig.11 In one embodiment, the spray cup 198 has a proximal end with a proximal opening 207, which is preferably adapted to receive the external threads 196 located at the distal end of the distal connector 190. In one embodiment, the spray cup 198 preferably has a closed distal wall 209 in which a spray opening 200 is formed for extruding tissue sealant through the distal connector 190. Grooves 211A, 21B are formed in the distal wall 209, which guide the tissue sealant into a vortex chamber 215 surrounding the spray opening 200, as disclosed in commonly assigned U.S. Patent Application Serial No. 16 / 593,799 filed on October 4, 2019, published on April 8, 2021 as US2021 / 0101162 (Attorney Docket No. ETH6050USNP1), the disclosure of which is hereby incorporated by reference herein.
[0107] refer to Fig.12 In one embodiment, the proximal connector 162 of the mixing and spraying assembly 106 is preferably inserted into the opening at the distal end of the elongated cannula 136 of the sealant delivery assembly. The distal end 166 of the proximal connector 162 has external threads 168, which preferably engage with internal threads (not shown) located at the proximal end 154 of the mixer housing 150. The mixing element 158 is located downstream of the first fluid conduit 170A and the second fluid conduit 170B, which are accessible at the distal end 166 of the proximal connector 162. The proximal end 184 ( Figure 8) is inserted into a blind hole 202 formed in the central shaft of the mixing element 158. The blind hole 202 of the mixing element 158 preferably extends along the longitudinal axis of the central shaft of the mixing element 158. In one embodiment, the blind hole 202 can extend up to about 1 / 2 to 3 / 4 of the length of the central shaft of the mixing element, and the proximal end of the ductile wire can be fully inserted into the blind hole 202 to ensure a secure connection between the mixing element and the proximal end of the ductile wire.
[0108] In one embodiment, the ductile section 110 ( Figure 1 ) has an extendable wire conduit 178 adapted to receive an extendable wire 182. The extendable wire conduit 178 receiving the extendable wire preferably extends along the length of the flexible shaft between its proximal end 174 and distal end 176. The flexible shaft 172 preferably includes a first tissue sealant conduit 180A and a second tissue sealant conduit 180B extending along the length of the flexible shaft 172. After the first fluid and the second fluid have been mixed together within the mixer housing 150, the first tissue sealant conduit 180A and the second tissue sealant conduit 180B preferably deliver the mixture of the first fluid and the second fluid (i.e., the flowable tissue sealant) to the spray tip assembly 112 for dispensing from the mixing and spraying assembly 106 ( Figure 1 ) is extruded from the distal end thereof.
[0109] In one embodiment, the mixer housing 150 preferably includes an elongated conduit 152 extending along the length of the mixer housing 150. A mixing element 158 (e.g., a static mixer) is preferably disposed within the elongated conduit 152 of the mixer housing 150. The proximal end 174B of the flexible shaft 172 and the proximal end of the ductile wire 182 are preferably disposed within the elongated conduit 152 at the proximal end 156 of the mixer housing 150.
[0110] The distal end 186 of the ductile wire 182 ( Figure 8 ) is preferably connected to the distal connector 190 to couple the distal connector 190 with the ductile wire 182 and the flexible shaft 172. The spray cup 198 is preferably threadedly connected to the external thread 196 ( Fig. 9A )superior.
[0111] refer to Fig.13A and Fig. 13B In one embodiment, the extensible section 110 ( Figure 1) preferably includes an expandable wire conduit 178 that receives an expandable wire 182. The flexible shaft 172 advantageously includes a first tissue sealant conduit 180A and a second tissue sealant conduit 180B that deliver a mixture of a first liquid and a second liquid (i.e., a flowable tissue sealant) to a portion of the sealant applicator 100 ( Figure 1 ) at the distal end of the spray tip assembly 112 ( Figure 7 In one embodiment, as the tissue sealant flows through the first tissue sealant conduit 180A and the second tissue sealant conduit 180B, the first liquid and the second liquid are mixed by the mixing element 158 located within the mixer housing 150 ( Fig.12 ).
[0112] refer to Fig.14A and Fig. 14B In one embodiment, the mixing and spraying assembly 106 is preferably fixed to the distal end of the elongated cannula 136 of the sealant delivery assembly 104. In one embodiment, the proximal connector 162 has a proximal end 164 inserted into the opening at the distal end of the elongated cannula 136 of the sealant delivery assembly 104. The proximal connector 162 has a first fluid channel 170A in fluid communication with the first flexible tube 138A. The proximal connector 162 also advantageously includes a second fluid channel 170B in fluid communication with the distal end of the second flexible tube 138B. The distal end of the proximal connector 162 advantageously has external threads 168 that engage with internal threads at the proximal end 154 of the mixer housing 150 for fixing the proximal end of the mixer housing to the distal end of the proximal connector 162. An O-ring 202 can be disposed between the outer surface of the proximal connector 162 and the inner surface of the mixer housing 154 to form a fluid-tight seal therebetween.
[0113] In one embodiment, the mixing element 158 is disposed within the elongated conduit 152 of the mixer housing 150. The mixing element 158 preferably has mixing fins 160 that protrude outwardly from the central axis of the mixing element. The proximal end 184 of the ductile wire 182 is inserted into the blind hole 202 ( Fig.12 ) to secure the proximal end of the ductile wire to the mixing element 158. The ductile wire 182 extends through the ductile wire conduit 178 ( Fig.12). In one embodiment, the blind hole formed in the central axis of the mixing element 158 extends about 1 / 2 to 3 / 4 of the length of the mixing element. In one embodiment, the proximal end of the ductile wire 182 is fully inserted into the blind hole of the central axis of the mixing element to ensure a secure connection between the ductile wire and the mixing element. The ductile wire 182 has a distal end 186 with a paddle-shaped attachment flange 188 (e.g., an attachment tab) that is connected to the distal connector 190 of the spray tip assembly 112. The spray cup 198 is preferably threadedly connected to the external threads 196 ( Fig. 9A )superior.
[0114] In one embodiment, from the first syringe barrel 142A ( Figure 4B ) is delivered to the mixing and spraying assembly 106 via the first flexible tube 138A and from the second syringe barrel 142B ( Figure 4B ) is delivered to the mixing and spraying assembly via the second flexible tube 138B. Upon reaching the proximal connector 162 of the mixing and spraying assembly 106, the first fluid and the second fluid are advantageously directed through the first fluid path 170A and the second fluid path 170B and into the opening at the proximal end of the mixer housing 150. In one embodiment, as the fluids flow in the distal direction DIR1 along the length of the mixing element 158, the first fluid and the second fluid are preferably mixed together by the mixing fins 160. In one embodiment, after the first fluid and the second fluid have been mixed together by the mixing element 158, the mixed solution is directed through the first tissue sealant conduit 180A and the second tissue sealant conduit 180B (which extend along the length of the flexible shaft 172) Fig.12 ). The mixed tissue sealant flows downstream through the first and second tissue sealant conduits 180A, 180B until directed through the distal connector 190 and into the spray cup 198 for extrusion through a dispensing port 200 located at the distal end of the spray cup 198. In other embodiments, the flexible shaft may have more than two tissue sealant conduits extending therethrough.
[0115] refer to Fig.15In one embodiment, the spray tip assembly 112 of the mixing and spraying assembly 106 can be angled relative to the longitudinal axis A1 of the elongated cannula 136 of the sealant delivery assembly 104. Thus, the surgeon can change the orientation of the spray tip 112 relative to the longitudinal axis A1 of the elongated cannula 136 to access difficult-to-reach locations within the surgical site. In one embodiment, the flexible shaft 172 enables the orientation of the spray tip 112 to be adjusted relative to the orientation or axis of the mixer housing 150 and the elongated cannula 136. When the surgeon bends the flexible shaft to angle the spray tip assembly relative to the axis of the cannula, the extensible wire extending through the flexible shaft maintains the curved shape of the flexible shaft established by the surgeon.
[0116] refer to Fig.16 In one embodiment, the flexible shaft 172 can be bent so that the spray tip assembly 112 extends along an axis A2 that is angled relative to the longitudinal axis A1 of the mixer housing 150 and / or the elongated cannula 136. The flexible shaft 172 preferably accommodates the ductile wire 182 ( Fig.14A ), which Fig.16 The spray tip assembly 112 is held in the angled orientation shown in FIG. The malleable wire may have shape memory properties for maintaining the orientation of the spray tip assembly that has been selected by the surgeon. The orientation of the spray tip assembly 112 may be adjusted to the desired orientation by grasping the distal connector 190 and / or the spray cup 198 to change the orientation of the spray tip assembly 112 relative to the longitudinal axis A1 of the mixer housing 150 and / or the elongated cannula 136. Fig.16 Although the present application is not limited to any particular theory of operation, it is believed that the mixing element 158 ( Fig.14A ) within the mixer housing 150 and positioning the mixer housing 150 at a location proximal to the flexible shaft 172 will enable the spray tip assembly 112 to have a shorter length (than the diameter of the mixer housing) and / or a smaller diameter, which will enable the surgeon to reach narrower locations and / or smaller cavities within the patient's body and position the spray tip assembly 112 at a more acute angle relative to the elongated cannula than is possible using a conventional spray tip assembly.
[0117] Fig.17 1 shows a side-by-side comparison of the mixing and spraying assembly 106 of the present patent application and the conventional spray tip assembly 50. In the mixing and spraying assembly 106 of the present patent application, the flexible shaft 172 of the ductile section 110 is disposed between the mixer housing 150 and the spray tip assembly 112. Thus, the mixer housing 150 ( Fig.14A) is located upstream of the flexible shaft 172, which enables the spray tip assembly 112 to have a shorter length L1. In one embodiment, the length L1 is about 15 mm. In contrast, in the conventional spray device 40, the spray tip assembly 50 includes a mixer housing 56, and the mixer housing is located distally (i.e., downstream) of the distal end of the flexible shaft 54. Because the conventional spray tip 50 includes the mixer housing 56, the length L2 of the conventional spray tip assembly is about 35 mm, which is more than twice the shorter length L1 of the spray tip assembly 112 disclosed in the present patent application. In addition, because the mixing assembly is not directly connected to the spray tip assembly, the spray tip assembly 112 disclosed in the present patent application has a first outer diameter OD1 that is smaller than the second outer diameter OD2 of the mixer housing and the conventional spray tip 50.
[0118] The user can manipulate the conventional spray tip 50 to a desired angle for sealant application.As described above, the spray tip 50 has a distal length L2 of approximately 35 mm, which may be too long for the spray tip to be used in a confined space such as the chest cavity.
[0119] In the present patent application, moving the mixing assembly 108 to the proximal end of the replaceable mixing and spray tip assembly 106 preferably reduces the diameter of the distal end of the spray tip assembly 112 to improve targeted application, and reduces the length L1 of the spray tip assembly 112 to less than 15 mm to improve accessibility.
[0120] Furthermore, due to its shorter length (ie, 15 mm versus 35 mm), the minimum headspace requirement H1 of the spray tip assembly 112 disclosed in the present patent application is less than the minimum headspace requirement H2 of the conventional spray tip design 40 .
[0121] refer to Fig.18In one embodiment, the syringe assembly 102 can be assembled with a vial assembly 206 having a vial assembly housing 232, a first vial 238A containing a first powdered reactive component, a second vial 238B containing a second powdered reactive component, a first piercing element 240A and a second piercing element 240A, as disclosed in commonly assigned U.S. Patent Application Serial No. __________ (Attorney Docket No. ETH6118USNP1), filed on the same date herewith, the disclosure of which is hereby incorporated herein by reference. In one embodiment, after the first and second end caps have been removed from the distal end of the syringe assembly 102 to expose the first and second applicator tips 124A, 124B, the distal end of the syringe assembly 102 can be coupled to the proximal end 234 of the vial assembly housing 232 of the vial assembly 206. The first dispensing tip 124A is preferably inserted into a first central opening (e.g., port) at the proximal end of the first puncture element 240A, and the second dispensing tip 124B is preferably inserted into a second central opening (e.g., port) at the proximal end of the second puncture element 240B.
[0122] refer to Fig.19 , after vial assembly 206 has been assembled with the distal end of syringe assembly 102, a first fluid disposed within first syringe barrel 116A of syringe assembly 102 is preferably in fluid communication with a first powder (e.g., a powdered reactive component) disposed within first powder chamber 260A of first vial 238A. Similarly, a second fluid disposed within second syringe barrel 116B of the syringe assembly is preferably in fluid communication with a second powder (e.g., a powdered reactive component) disposed within second powder chamber 260B of second vial 238B.
[0123] Fig. 20The distal end of the syringe assembly 102 connected to the proximal end of the vial assembly 206 is shown. In one embodiment, the first piercing element 240A and the second piercing element 240B can extend to pierce the sealing membrane 248A, 248B, which seals the vial opening at the proximal end of the respective first vial 238A and the second vial 238B. The syringe assembly includes a first syringe barrel 116A, which has a first fluid chamber 142A containing a first fluid, which is used to reconstitute the first powder in the first powder chamber 260A of the first vial 238A. The syringe assembly 102 also advantageously includes a second syringe barrel 116B, which has a second fluid chamber 142B, which contains a second fluid for reconstructing the second powder in the second powder chamber 260B of the second vial 238B. The first syringe barrel 116A is connected to the proximal end of the vial assembly 206 so that the first distribution top 124A of the first syringe barrel 116A is aligned with the first vial opening 246A of the first vial 238A and is in fluid communication with it. The first vial 238A has a first powder chamber 160A for accommodating a first powder, which will be reconstructed using the first fluid in the first fluid chamber 142A of the first syringe barrel 116A. The second distribution top 124B at the distal end of the second syringe barrel 116B is preferably aligned with the second vial opening 246B of the second vial 238B. The second vial 238B preferably includes a second powder chamber 260B for accommodating a second powder, which will be reconstructed using the second fluid in the second fluid chamber 142B of the second syringe barrel 116B.
[0124] exist Fig. 20 During the stages shown in , the first fluid and the first powder are kept isolated from the second fluid and the second powder.
[0125] In one embodiment, the first fluid in the fluid chamber 142A of the first syringe 116A is mixed with the first powder in the first vial 238A by advancing and retracting the double barrel plunger 118 in the distal direction DIR1 and the proximal direction DIR2. When the first plunger rod 120A is advanced toward the distal end of the syringe assembly 114, the first fluid in the first fluid chamber 142A of the first syringe 116A is forced into the first powder chamber 260A of the first vial 238A for reconstitution of the first powder into a first therapeutic solution. When the first plunger rod 120 is retracted from the distal end of the syringe assembly 102, the first therapeutic solution (i.e., a mixture of the first powder and the first fluid) is drawn back into the first fluid chamber 142A of the first syringe 116A. The first plunger rod 120A can reciprocate back and forth between an extended position and a retracted position for thoroughly mixing the first fluid and the first powder to form a first precursor solution (e.g., a first fluid; a first solution). In one embodiment, after the first precursor solution has been formed, the first plunger rod 120A is preferably fully retracted to draw the entire volume of the first precursor solution back into the first fluid chamber 142A of the first syringe 116A.
[0126] In one embodiment, the second fluid in the second fluid chamber 142B of the second syringe 116B is mixed with the second powder in the second vial 238B by advancing and retracting the double barrel plunger 118 in the distal direction DIR1 and the proximal direction DIR2. When the second plunger rod 120B is advanced toward the distal end of the syringe assembly 102 (i.e., in the direction DIR1), the second fluid in the second fluid chamber 142B of the second syringe 116B is forced into the second powder chamber 260B of the second vial 238B for reconstitution of the second powder into a second therapeutic solution. When the second plunger rod 120B is retracted from the distal end of the syringe assembly 102 (i.e., in the direction DIR2), the second therapeutic solution (i.e., a mixture of the second powder and the second fluid) is drawn back into the second fluid chamber 142B of the second syringe 116B. The second plunger rod 120B can reciprocate back and forth between an extended position and a retracted position for thoroughly mixing the second fluid and the second powder to form a second precursor solution (e.g., a flowable fluid). In one embodiment, after the second precursor solution has been formed, the second plunger rod 120B is preferably fully retracted to draw the entire volume of the second precursor solution into the second fluid chamber 142B of the second syringe 116B.
[0127] refer to Figure 1 and Fig. 20In one embodiment, after the first and second precursor solutions have been generated and drawn into the first and second fluid chambers 142A, 142B of the respective first and second syringes 116A, 116B of the syringe assembly 102, the vial assembly 206 can be disconnected from the distal end of the syringe assembly 102, whereupon the sealant delivery assembly 104 can be secured to the distal end of the syringe assembly 102 for extruding the mixture of the first and second precursor solutions (i.e., tissue sealant) from the spray tip assembly 112 located at the distal end of the sealant applicator 100. In one embodiment, the sealant delivery assembly housing 128 at the proximal end of the sealant delivery assembly 104 is preferably connected to the distal end of the syringe assembly 102. The cannula 136 preferably extends toward the distal end of the sealant delivery assembly 104.
[0128] After the sealant delivery assembly 104 has been secured to the distal end of the syringe assembly 102, the first fluid chamber 142A of the first syringe 116A containing the first precursor solution is preferably connected via the first flexible tube 138A ( Figure 4B ) is in fluid communication with the mixing and spraying assembly 106. The second fluid chamber 142B of the second syringe 116B containing the second precursor solution is preferably connected to the second flexible tube 138B ( Figure 4B ) is fluidically connected to the mixing and injection assembly 106.
[0129] In one embodiment, the double barrel plunger 118 is depressed in a distal direction indicated as DIR1 to force the first precursor solution and the second precursor solution to flow out of the first fluid chamber 142A and the second fluid chamber 142B of the respective first syringe 116A and the second syringe 116B, whereupon the first precursor solution and the second precursor solution flow through the respective first flexible tube 138A and the second flexible tube 138B ( Figure 4A ) until they reach the mixing and spraying assembly 106. Upon reaching the mixing and spraying assembly 106, the first precursor solution and the second precursor solution pass through the mixing element 158 ( Fig.14A ) are mixed together, whereupon the first precursor solution and the second precursor solution react with each other to form a tissue sealant or hemostatic agent, which passes through the ductile section 110 to be ejected from the spray cup 198 ( Fig.14A ) is extruded through the dispensing opening 200.
[0130] Although the foregoing is directed to embodiments of the present invention, other and further embodiments of the present invention may be devised without departing from the basic scope of the present invention, which is limited only by the scope of the following claims. For example, the present invention contemplates that any feature shown in any embodiment described herein or incorporated by reference may be combined with any feature shown in any other embodiment described herein or incorporated by reference and still fall within the scope of the present invention.
Claims
1. A mixing and spraying assembly for a tissue sealant, comprising: a mixing assembly located at a proximal end of the mixing and spraying assembly; a spray tip assembly located at a distal end of the mixing and spraying assembly; An expandable section has a proximal end connected to the mixing assembly and a distal end connected to the spray tip assembly for enabling the spray tip assembly to be angled relative to the mixing assembly.
2. The mixing and spraying assembly of claim 1, wherein the extendable section comprises: a flexible shaft having a proximal end, a distal end, and a length extending between the proximal and distal ends of the flexible shaft; an expandable wire conduit extending along the length of the flexible shaft; a stretch wire disposed in the stretch wire conduit of the flexible shaft, the stretch wire having a length greater than the length of the flexible shaft, wherein the stretch wire has a proximal end extending beyond the proximal end of the flexible shaft and connected to the mixing assembly and a distal end extending beyond the distal end of the flexible shaft and connected to the spray tip assembly.
3. The mixing and spraying assembly of claim 2, wherein the mixing assembly comprises: a mixer housing having a proximal end, a distal end, and a mixer housing conduit extending along a length of the mixer housing from the proximal end to the distal end of the mixer housing; A mixing element is disposed within the mixer housing conduit, wherein the proximal end of the ductile wire extending beyond the proximal end of the flexible shaft is secured to the mixing element.
4. The mixing and spraying assembly of claim 3, wherein the mixing element comprises: a static mixer having a central axis extending along a length of the static mixer; the central shaft of the static mixer, the central shaft having a proximal end and a distal end; a blind hole formed in the central shaft of the static mixer, the blind hole extending from the distal end of the central shaft toward the proximal end of the central shaft; The proximal end of the ductile wire is disposed in the blind hole formed in the central shaft of the static mixer for connecting the proximal end of the ductile wire to the static mixer.
5. The mixing and spraying assembly of claim 4, wherein the mixing assembly further comprises: a proximal connector having a proximal end configured for insertion into an opening at a distal end of an elongated cannula of a sealant applicator device and a distal end having external threads; The mixer housing has internal threads at the proximal end of the mixer housing, the internal threads being configured to engage with the external threads at the distal end of the proximal connector for securing the mixer housing to the proximal connector.
6. The mixing and spraying assembly of claim 5, wherein the proximal connector comprises: a first fluid passage extending from the proximal end to the distal end of the proximal connector, wherein the first fluid passage is in fluid communication with the proximal end of the static mixer; a second fluid passage extending from the proximal end to the distal end of the proximal connector, wherein the second fluid passage is in fluid communication with the proximal end of the static mixer; a first flexible tube disposed in the first fluid passage of the proximal connector for supplying a first fluid to the proximal end of the mixer housing; A second flexible tube is disposed in the second fluid passage of the proximal connector for supplying a second fluid to the proximal end of the mixer housing.
7. The mixing and spraying assembly of claim 6, wherein the static mixer is adapted to mix the first fluid and the second fluid whereupon the first fluid and the second fluid react together to form a tissue sealant.
8. The mixing and spraying assembly of claim 7, wherein the flexible shaft of the extendable section includes one or more tissue sealant conduits extending along the length of the flexible shaft for supplying the tissue sealant to the spray tip assembly.
9. The mixing and spraying assembly of claim 8, wherein the extendable wire conduit extends along a central axis of the flexible shaft, and wherein the one or more tissue sealant conduits of the flexible shaft include a first tissue sealant conduit and a second tissue sealant conduit extending along opposite sides of the extendable wire conduit.
10. The mixing and spraying assembly of claim 9, wherein the spray tip assembly comprises: a distal connector having a proximal end and a distal end having external threads; the proximal end of the distal connector, the proximal end having a central opening for receiving the distal end of the flexible shaft; the distal end of the extensible wire, the distal end extending beyond the distal end of the flexible shaft and connected to the distal connector; a spray cup having a spray opening for extruding the tissue sealant supplied by the first and second tissue sealant conduits passing through the flexible shaft, the spray cup having a tubular proximal end with an internal thread configured to engage with the external thread at the distal end of the distal connector for fixing the spray cup to the distal connector.
11. A mixing and spraying assembly according to claim 10, wherein the distal end of the ductile wire fixed to the distal connector of the spray tip assembly includes a paddle-shaped flange, the width of the paddle-shaped flange being greater than the diameter of the section of the ductile wire extending to the proximal end of the ductile wire.
12. A mixing and spraying assembly for extruding a tissue sealant, comprising: a mixing assembly configured to mix a first fluid and a second fluid that chemically react together to form a tissue sealant; a spray tip assembly configured to extrude the tissue sealant; a stretchable section having a proximal end connected to the mixing assembly and a distal end connected to the spray tip assembly for enabling the spray tip assembly to be angled relative to the mixing assembly, wherein the stretchable section has one or more tissue sealant conduits extending along the length of the stretchable section for delivering the tissue sealant from the mixing assembly to the spray tip assembly.
13. The mixing and spraying assembly of claim 12, wherein the extendable section comprises: a flexible shaft having an expandable wire conduit extending from the proximal end to the distal end of the flexible shaft; A stretch wire is disposed within the stretch wire catheter, the stretch wire having a proximal end extending beyond the proximal end of the flexible shaft to connect to the mixing assembly and a distal end extending beyond the distal end of the flexible shaft to connect to the spray tip assembly.
14. The mixing and spraying assembly of claim 13, further comprising: the mixing assembly comprising a mixer housing having a proximal end, a distal end, and a mixer housing conduit extending from the proximal end to the distal end of the mixer housing; the mixing assembly comprising a mixing element disposed within the mixer housing conduit of the mixer housing; the spray tip assembly including a distal connector coupled to the distal end of the flexible shaft and a spray cup having a spray opening secured to a distal end of the distal connector; The proximal end of the ductile wire and the distal end of the ductile wire, the proximal end being secured to the mixing element disposed within the mixer housing and the distal end being secured to the distal connector of the spray tip assembly.
15. The mixing and spraying assembly of claim 15, wherein the mixing element comprises: a static mixer having a central axis extending along a length of the static mixer; the central shaft of the static mixer, the central shaft having a proximal end and a distal end; A blind hole is formed in the central shaft of the static mixer, the blind hole extending from the distal end of the central shaft toward the proximal end of the central shaft, wherein the proximal end of the ductile wire is disposed in the blind hole formed in the central shaft of the static mixer for connecting the proximal end of the ductile wire to the static mixer.
16. The mixing and spraying assembly of claim 14, wherein the mixer housing has a longitudinal axis extending from the proximal end to the distal end of the mixer housing, and wherein the extendable section enables the spray tip assembly to be angled relative to the longitudinal axis of the mixer housing.
17. The mixing and spraying assembly of claim 14, wherein the mixer housing has a first outer diameter and the spray tip assembly has a second outer diameter that is smaller than the first outer diameter of the mixer housing.
18. A method of extruding a tissue sealant, comprising: obtaining a mixing and spraying assembly comprising a mixing assembly, a spray tip assembly, and an extendable section having a proximal end connected to the mixing assembly and a distal end connected to the spray tip assembly for spacing the spray tip assembly from the mixing assembly and for enabling the spray tip assembly to be angled relative to the mixing assembly; directing a first fluid and a second fluid into the proximal end of the mixing assembly; mixing the first fluid and the second fluid within the mixing assembly, whereupon the first fluid and the second fluid react together to form a tissue sealant; passing the tissue sealant through one or more tissue sealant conduits extending through the expandable section to supply the tissue sealant to the spray tip assembly; The tissue sealant is extruded from a distal end of the spray tip assembly.
19. The method of claim 18, wherein the first fluid comprises fibrinogen and the second fluid comprises thrombin that reacts with the fibrinogen to form the tissue sealant.
20. The method of claim 18, wherein the extendable section of the mixing and spraying assembly comprises: a flexible shaft having an expandable wire conduit extending from a proximal end to a distal end of the flexible shaft; a stretch wire disposed within the stretch wire catheter, the stretch wire having a proximal end extending beyond the proximal end of the flexible shaft and a distal end extending beyond the distal end of the flexible shaft; The proximal end of the ductile wire and the distal end of the ductile wire, the proximal end connected to the mixing assembly and the distal end connected to the spray tip assembly.
